1h-3-benzazepin-7-ol, 8-bromo-2,3,4,5-tetrahydro-3-methyl-5-phenyl- and butaclamol

1h-3-benzazepin-7-ol, 8-bromo-2,3,4,5-tetrahydro-3-methyl-5-phenyl- has been researched along with butaclamol in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (25.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's3 (75.00)2.80

Authors

AuthorsStudies
George, SR; Guan, HC; Laurier, LG; Ng, G; Niznik, HB; O'Dowd, BF; Seeman, P; Sunahara, RK; Torchia, J; Van Tol, HH1
Alberts, I; Harding, WW; Juarez, R; Karki, A; Namballa, HK1
Alberts, I; Giri, R; Harding, WW; Namballa, HK; Sarker, A1
Cordone, P; Gallicchio, E; Harding, WW; Muniz, B; Namballa, HK; Pal, RK1

Other Studies

4 other study(ies) available for 1h-3-benzazepin-7-ol, 8-bromo-2,3,4,5-tetrahydro-3-methyl-5-phenyl- and butaclamol

ArticleYear
Cloning of the gene for a human dopamine D5 receptor with higher affinity for dopamine than D1.
    Nature, 1991, Apr-18, Volume: 350, Issue:6319

    Topics: Amino Acid Sequence; Animals; Base Sequence; Binding, Competitive; Blotting, Northern; Brain; Cell Line; Cell Membrane; Cloning, Molecular; Dopamine; Humans; Kinetics; Molecular Sequence Data; Molecular Weight; Oligonucleotide Probes; Rats; Receptors, Dopamine; Receptors, Dopamine D1; Receptors, Dopamine D5; RNA, Messenger; Sequence Homology, Nucleic Acid; Transfection

1991
Identification of C10 nitrogen-containing aporphines with dopamine D
    Bioorganic & medicinal chemistry letters, 2020, 04-15, Volume: 30, Issue:8

    Topics: Aporphines; Dopamine Agonists; Dose-Response Relationship, Drug; Humans; Ligands; Molecular Docking Simulation; Molecular Structure; Receptors, Dopamine D1; Receptors, Dopamine D5; Structure-Activity Relationship

2020
Synthesis and dopamine receptor pharmacological evaluations on ring C ortho halogenated 1-phenylbenzazepines.
    Bioorganic & medicinal chemistry letters, 2020, 08-15, Volume: 30, Issue:16

    Topics: Benzazepines; Dopamine Antagonists; Dose-Response Relationship, Drug; Halogenation; Molecular Structure; Receptors, Dopamine D1; Structure-Activity Relationship

2020
New tetrahydroisoquinoline-based D
    Bioorganic & medicinal chemistry letters, 2021, 06-15, Volume: 42

    Topics: Dose-Response Relationship, Drug; Humans; Ligands; Molecular Structure; Receptors, Dopamine D3; Structure-Activity Relationship; Tetrahydroisoquinolines; Xylenes

2021